APA

Mujtaba A., Taher M. A., Hazza M. A., Al-Rubaye H. M., Kata A. H., AbdulWahab H., AbdulBari A. & AlRubay H. K. (2018). The Effect of Spironolactone on the Incidence of Contrast-Induced Nephropathy in Patients Undergoing Cardiac Catheterization: Study Design and Rationale. : Cardiology and therapy.

Chicago

Mujtaba Alhasan, Taher Mohammed A, Hazza Mazin A, Al-Rubaye Hassan M, Kata Asaad H, AbdulWahab Hamid, AbdulBari AbdulAmeer and AlRubay Hayder K. 2018. The Effect of Spironolactone on the Incidence of Contrast-Induced Nephropathy in Patients Undergoing Cardiac Catheterization: Study Design and Rationale. : Cardiology and therapy.

Harvard

Mujtaba A., Taher M. A., Hazza M. A., Al-Rubaye H. M., Kata A. H., AbdulWahab H., AbdulBari A. and AlRubay H. K. (2018). The Effect of Spironolactone on the Incidence of Contrast-Induced Nephropathy in Patients Undergoing Cardiac Catheterization: Study Design and Rationale. : Cardiology and therapy.

MLA

Mujtaba Alhasan, Taher Mohammed A, Hazza Mazin A, Al-Rubaye Hassan M, Kata Asaad H, AbdulWahab Hamid, AbdulBari AbdulAmeer and AlRubay Hayder K. The Effect of Spironolactone on the Incidence of Contrast-Induced Nephropathy in Patients Undergoing Cardiac Catheterization: Study Design and Rationale. : Cardiology and therapy. 2018.